New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants.
Company’s Keywords:
medical devices, medical device r, d, blood management, blood products, clinical research, blood collection, blood storage, medical device management, transfusion medicine, biomechanical innovation
<11
<5392000
<
Your request has been submitted successfully.
Own or work here?